Add this topic to your myFT Digest for news straight to your inbox
US company needs new ideas but multibillion dollar deal will not be a guaranteed cure
Pfizer among those risking backlash with new year increases on many medicines
Irish pharma company proposes deal after initial rebuff
US stocks slip on call for September rate rise
Simplification is good but the units face the same challenges
SMEs are spearheading the growth of new industries, finds Simon Mee
Group confident about expansion in the region
Hundreds of millions of pounds spent on vaccines
International Edition